Increased Expression of Plasminogen Activator Inhibitor-1 in Cardiomyocytes Contributes to Cardiac Fibrosis after Myocardial Infarction

American Journal of Pathology

Volumn 164, Issue 2, 2004, Pages 449-456

  Takeshita, Kyosuke ^a   Hayashi, Mutsuharu ^a   Iino, Shigeo ^a   Kondo, Takahisa ^a   Inden, Yasuya ^a   Iwase, Mitsunori ^b   Kojima, Tetsuhito ^b   Hirai, Makoto ^b   Ito, Masafumi ^c   Loskutoff, David J ^e   Saito, Hidehiko ^d   Murohara, Toyoaki ^a   Yamamoto, Koji ^c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENZYME INACTIVATION; FIBROSING ALVEOLITIS; FIBROSIS; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; WILD TYPE; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; MAST CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAST CELLS; MICE; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PLASMINOGEN ACTIVATOR INHIBITOR 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 1542289735     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63135-5     Document Type: Article

References (45)

1. Whittaker P, Boughner DR, Kloner RA: Role of collagen in acute myocardial infarct expansion. Circulation 1991, 84:2123-2134
2. Zannad F, Dousset B, Alla F: Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship. Hypertension 2001, 38:1227-1232
3. Kim HE, Dalal SS, Young E, Legato MJ, Weisfeldt ML, D'Armiento J: Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J Clin Invest 2000, 106:857-866
4. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, Lopez-Anaya A, McClure KF, Mitchell PG, Libby P, Lee RT: Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 1999, 99: 3063-3070
5. Li YY, Feldman AM, Sun Y, McTiernam CF: Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 1998, 98:1728-1734
6. Creemers EEJM, Cleutjens J, Smits JFM, Daemen MJAP: Matrix metalloproteinase inhibition after myocardial infarction. A new approach to prevent heart failure? Circ Res 2001, 89:201-210
7. Creemers EEJM, Cleutjens J, Smits J, Heymans S, Moons L, Collen D, Daemen M, Carmeliet P: Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol 2000, 156:1865-1873
8. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JPM, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P: Inhibition of plasminogen activators or matrix metalloproteinases prevent cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999, 10:1135-1142
9. Quax PHA, van den Hoogen CM, Verheijen JH, Padro T, Zeheb R, Gelehrter TD, van Berkel TJC, Kuiper J, Emeis JJ: Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 1990, 265:15560-15563
10. Sawdey MS, Loskutoff DJ: Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo: tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β. J Clin Invest 1991, 88:1346-1353
11. Hayashidani S, Tsutsui H, Shiomi T, Suematsu N, Kinugawa S, Ide T, Wen J, Takeshita A: Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002, 105: 868-873
12. Iwase M, Yokota M, Kitaichi K, Wang L, Takagi K, Nagasaka T, Izawa H, Hasegawa T: Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor. Crit Care Med 2001, 29:609-617
13. Carmeliet P, Kieckens L, Schoonjans L, Ream B, van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC: Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest 1993, 92:2746-2755
14. Kunishima S, Hayashi K, Kobayashi S, Naoe T, Ohno R: New enzyme-linked immunosorbent assay for glycocalicin in plasma. Clin Chem 1991, 37:169-172
15. Ishiguro K, Kojima T, Kadomatsu K, Nakayama Y, Takagi A, Suzuki M, Takeda N, Ito M, Yamamoto K, Matsushita T, Kusugami K, Muramatsu T, Saito H: Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest 2000, 106:873-878
16. Yamamoto K, Loskutoff DJ: Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 1996, 97:2440-2451
17. Yamamoto K, Takeshita K, Shimokawa T, Yi H, Isobe K, Loskutoff DJ, Saito H: Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals. Proc Natl Acad Sci USA 2002, 99:890-895
18. Nishioka K, Kobayashi Y, Katayama I, Takijiri C: Mast cell numbers in diffuse scleroderma. Arch Dermatol 1987, 123:205-208
19. Hara M, Ono K, Hwang MW, Iwasaki A, Okada M, Nakatani K, Sasayama S, Matsumori A: Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 2002, 195:375-381
20. Kaikita K, Fogo AB, Ma L, Schoenhard JA, Brown NJ, Vaughan DE: Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation 2001, 104:839-844
21. Gersch C, Dewald O, Zoerlein M, Michael LH, Entman ML, Frangogiannis NG: Mast cells and macrophages in normal C57/BL/6 mice. Histochem Cell Biol 2002, 118:41-49
22. Askari AT, Brennan M-L, Zhou X, Drinko J, Morehead A, Thomas JD, Topol EJ, Hazen SL, Penn MS: Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med 2003, 197:615-624
23. Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH, Drew AF: Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest 2000, 106:1341-1350
24. Brown NJ, Vaughan DE, Fogo AB: The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease. Semin Nephrol 2002, 22:399-406
25. Yamamoto K, Saito H: A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders. Int J Hematol 1998, 68:371-385
26. Zaman AK, Fujii S, Sawa H, Goto D, Ishimori N, Watano K, Kaneko T, Furumoto T, Sugawara T, Sakuma I, Kitabatake A, Sobel BE: Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice. Circulation 2001, 103:3123-3128
27. Macfelda K, Weiss TW, Kaun C, Breuss JM, Kapeller B, Zorn G, Oberndorfer U, Voegele-Kadletz M, Huber-Beckmann R, Ullrich R, Binder BR, Losert UM, Maurer G, Pacher R, Huber K, Wojta J: Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1α, tumor necrosis factor-a, transforming growth factor-β and oncostatin M in human cardiac myocytes. J Mol Cell Cardiol 2002, 34:1681-1691
28. Carroll SM, Nimmo LE, Knoepfler PS, White FC, Bloor CM: Gene expression in a swine model of right ventricular hypertrophy: intercellular adhesion molecule, vascular endothelial growth factor and plasminogen activators are upregulated during pressure overload. J Mol Cell Cardiol 1995, 27:1427-1441
29. Takeshita K, Yamamoto K, Ito M, Kondo T, Matsushita T, Hirai M, Kojima T, Nabeshima Y, Loskutoff DJ, Saito H, Murohara T: Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, "klotho" mouse. Semin Thromb Hemost 2002, 28:545-553
30. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S: Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 1998, 98:149-156
31. Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U: Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arterioscler Thromb Vasc Biol 2000, 20:2019-2023
32. Vaughan DE, Rouleau JL, Ridker PM, Arnold JM, Menapace FJ, Pfeffer MA: Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators. Circulation 1997, 96:442-447
33. Sinkovic A: Pretreatment plasminogen activator inhibitor-1 (PAI-1) levels and the outcome of thrombolysis with streptokinase in patients with acute myocardial infarction. Am Heart J 1998, 136:406-411
34. Ruoss SJ, Hartmann T, Caughey GH: Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991, 88:493-429
35. Marone G, de-Crescenzo G, Adt M, Patella V, Arbustini E, Genovese A: Immunological characterization and functional importance of human heart mast cells. Immunopharmacology 1995, 31:1-18
36. Laine P, Kaartinen M, Penttila A, Panula P, Paavonen T, Kovanen PT: Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 1999, 99:361-369
37. Patella V, Marino I, Arbustini E, Lampater-Schummert B, Verga L, Adt M, Marone G: Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 1998, 97:971-978
38. Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M: Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation 2003, 107: 2555-2558
39. Wojta J, Kaun C, Zorn G, Ghannadan M, Hauswirth AW, Sperr WR, Fritsch G, Printz D, Binder BR, Schatzl G, Zwirner J, Maurer G, Huber K, Valent P: C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils. Blood 2002, 100:517-523
40. Lyons RM, Gentry LE, Purchio AF, Moses HL: Mechanism of activation of latent recombinant transforming growth factor-β1 by plasmin. J Cell Biol 1990, 110:1361-1367
41. Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, Tipping P, Drew A, Eeckhout Y, Shapiro S, Lupu F, Collen D: Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 1997, 17:439-444
42. Hopkins WE, Fujii S, Sobel BE: Synergistic induction of plasminogen activator inhibitor type-1 in HEP G2 cells by thrombin and transforming growth factor-β. Blood 1992, 79:75-81
43. Yamamoto K, Loskutoff DJ: Expression of transforming growth factor-β and tumor necrosis factor-α in the plasma and tissues of mice with lupus nephritis. Lab Invest 2000, 80:1561-1570
44. Reisdorf P, Lawrence DA, Sivan V, Klising E, Martin MT: Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 signaling in myofibroblasts from skin fibrosis. Am J Pathol 2001, 159:263-272
45. Lindstedt KA, Wang Y, Shiota N, Saarinen J, Hyytiainen M, Kokkonen JO, Keski-Oja J, Kovanen PT: Activation of paracrine TGF-β1 signaling upon stimulation and degradation of rat serosal mast cells: a novel function for chymase. EMBO J 2001, 15:1377-1388